Barbara Hildebrandt
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
Silzle T, Blum S, Kasprzak A, Nachtkamp K, Rudelius M, Hildebrandt B, Götze K, Gattermann N, Lauseker M, Germing U. The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score. Cancers (Basel) 2023; 15
Jul 11, 2023The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
Jul 11, 2023Cancers (Basel) 2023; 15
Silzle Tobias, Blum Sabine, Kasprzak Annika, Nachtkamp Kathrin, Rudelius Martina, Hildebrandt Barbara, Götze Katharina S, Gattermann Norbert, Lauseker Michael, Germing Ulrich
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients
Silzle T, Blum S, Schuler E, Kaivers J, Rudelius M, Hildebrandt B, Gattermann N, Haas R, Germing U. Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients. Blood Cancer J 2019; 9:63.
Aug 9, 2019Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients
Aug 9, 2019Blood Cancer J 2019; 9:63
Silzle Tobias, Blum Sabine, Schuler Esther, Kaivers Jennifer, Rudelius Martina, Hildebrandt Barbara, Gattermann Norbert, Haas Rainer, Germing Ulrich